Blog - Page 3 of 10 - Frier Levitt Government Affairs

Health Policy Check Up News

Our blog provides timely insight on the latest industry trends. We discuss manufacturing, acute and post-acute care issues.
Stay current with our latest insights.

May 14, 2019

HHS’ Final Rule Requiring Drug Prices in TV Advertising Presents an Opportunity for Manufacturers

May 9, 2019

North Dakota: A Model Opportunity for Advancing Pharmacy Law

May 8, 2019

Service Spotlight: Frier Levitt Government Affairs Gap Analysis

May 7, 2019

Is Your State a “True” Any Willing Provider State?

April 30, 2019

CMS Makes Proposed Copay Accumulator Rule Final

April 26, 2019

Demystifying CBD: What You Need to Know About the Growing Cannabidiol Market

April 8, 2019

FDA Seeking Comments on New Guidance Regarding Rare Diseases

March 29, 2019

What You Need to Know about Biosimilars with Brian Lehman, Director, Medical Account Management and Strategic Alliances for Sandoz Inc.

March 28, 2019

Biosimilar Naming: Where We’ve Been and Where We Are

March 27, 2019

Will PBM Transparency Help Biosimilar Utilization?